Radius Health (Cambridge, MA) a clinical-stage biopharmaceutical company focused on osteoporosis and women’s health, closed a $66M Series C financing. Participants include Brookside Capital, Saints Capital, Nordic Bioscience, Ipsen Pharma, MPM Capital, BB Biotech Ventures, The Wellcome Trust, HealthCare Ventures and Scottish Widows Investment Partnership.